全文获取类型
收费全文 | 62960篇 |
免费 | 3469篇 |
国内免费 | 1433篇 |
专业分类
耳鼻咽喉 | 274篇 |
儿科学 | 3317篇 |
妇产科学 | 273篇 |
基础医学 | 3567篇 |
口腔科学 | 141篇 |
临床医学 | 9294篇 |
内科学 | 12306篇 |
皮肤病学 | 402篇 |
神经病学 | 2334篇 |
特种医学 | 1479篇 |
外国民族医学 | 5篇 |
外科学 | 4572篇 |
综合类 | 11953篇 |
预防医学 | 3198篇 |
眼科学 | 269篇 |
药学 | 6571篇 |
56篇 | |
中国医学 | 2623篇 |
肿瘤学 | 5228篇 |
出版年
2024年 | 19篇 |
2023年 | 819篇 |
2022年 | 1447篇 |
2021年 | 2223篇 |
2020年 | 2533篇 |
2019年 | 2696篇 |
2018年 | 1591篇 |
2017年 | 1967篇 |
2016年 | 2120篇 |
2015年 | 2172篇 |
2014年 | 4919篇 |
2013年 | 4746篇 |
2012年 | 4154篇 |
2011年 | 4421篇 |
2010年 | 3419篇 |
2009年 | 3083篇 |
2008年 | 2938篇 |
2007年 | 2937篇 |
2006年 | 2644篇 |
2005年 | 2259篇 |
2004年 | 1902篇 |
2003年 | 1545篇 |
2002年 | 1222篇 |
2001年 | 1175篇 |
2000年 | 917篇 |
1999年 | 827篇 |
1998年 | 683篇 |
1997年 | 580篇 |
1996年 | 588篇 |
1995年 | 587篇 |
1994年 | 539篇 |
1993年 | 421篇 |
1992年 | 407篇 |
1991年 | 379篇 |
1990年 | 314篇 |
1989年 | 308篇 |
1988年 | 288篇 |
1987年 | 210篇 |
1986年 | 189篇 |
1985年 | 331篇 |
1984年 | 253篇 |
1983年 | 151篇 |
1982年 | 192篇 |
1981年 | 156篇 |
1980年 | 130篇 |
1979年 | 131篇 |
1978年 | 97篇 |
1977年 | 79篇 |
1976年 | 64篇 |
1975年 | 30篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial
Areej El-Jawahri MD Marlise R. Luskin MD Joseph A. Greer PhD Lara Traeger PhD Mitchell Lavoie BS Dagny Marie Vaughn BS Stephanie Andrews BS Daniel Yang BS Kofi Y. Boateng BS Richard A. Newcomb MD Nneka N. Ufere MD Amir T. Fathi MD Gabriela Hobbs MD Andrew Brunner MD Gregory A. Abel MD Richard M. Stone MD Daniel J. DeAngelo MD PhD Martha Wadleigh MD Jennifer S. Temel MD 《Cancer》2023,129(7):1075-1084
2.
Dikshat Gopal Gupta PhD Neelam Varma MD Praveen Sharma MD Mihai I. Truica MD PhD Sarki A. Abdulkadir MD PhD Parmod Singh PhD Man Updesh Singh Sachdeva MD Shano Naseem MD Mohammad Rizwan Siddiqui PhD Parveen Bose MSc Jogeshwar Binota MSc Pankaj Malhotra MD Alka Khadwal MD Amita Trehan Subhash Varma MD 《Cancer》2023,129(21):3390-3404
3.
Signe Holst Søegaard Klaus Rostgaard Mads Kamper-Jørgensen Kjeld Schmiegelow Henrik Hjalgrim 《International journal of cancer. Journal international du cancer》2023,152(9):1817-1826
Childhood acute lymphoblastic leukaemia (ALL) is suggested to result from a dysregulated immune response to infections in children with a preleukaemic state. Childcare in early life supposedly may protect against childhood ALL by facilitating sufficient exposure to infections to stimulate and ensure normal maturation of the immune system. We assessed the association between childcare attendance before age 2 years and risk of childhood ALL in a register-based cohort study, including all children aged 2 to 14 years born in Denmark during 1991 to 2014 with available childcare information recorded in the Danish Childcare Database (n = 1 116 185). Cox regression was used to estimate hazard ratios (HRs) comparing children enrolled in childcare and children not enrolled before age 2 years. Further, we assessed the association according to age at enrolment, type of childcare facility and specific ALL subtypes. During 10 460 811 person-years of follow-up, 460 children developed ALL at ages 2 to 14 years. Of these, 57 (12.4%) never attended childcare before age 2 years compared with 10.6% in the total cohort. Compared with homecare, childcare attendance before age 2 years was associated with a statistically non-significantly, marginally decreased risk of childhood ALL with adjusted HR = 0.87 (95% confidence interval [CI]: 0.65-1.16). Risk estimates did neither vary statistically significantly by age at enrolment nor by type of childcare facility and also not between childhood ALL subtypes, including frequently prenatally initiated ALL subtypes. Results from this large, nationwide register-based study provided no evidence that childcare attendance in the first years of life protects against childhood ALL. 相似文献
4.
5.
Joseph Wheatley Zhengyang Liu Joel Loth Mark P. Plummer Jahan C. Penny-Dimri Reny Segal Julian Smith Luke A. Perry 《Acta anaesthesiologica Scandinavica》2023,67(2):131-141
Background
Patients undergoing cardiac surgery are at significant risk of developing postoperative acute kidney injury (AKI). Neutrophil–lymphocyte ratio (NLR) is a widely available inflammatory biomarker which may be of prognostic value in this setting.Methods
We conducted a systematic review and meta-analysis of studies reporting associations between perioperative NLR with postoperative AKI. We searched Medline, Embase and the Cochrane Library, without language restriction, from inception to May 2022 for relevant studies. We meta-analysed the reported odds ratios (ORs) with 95% confidence intervals (CIs) for both elevated preoperative and postoperative NLR with risk of postoperative AKI and need for renal replacement therapy (RRT). We conducted a meta-regression to explore inter-study statistical heterogeneity.Results
Twelve studies involving 10,724 participants undergoing cardiac surgery were included, with eight studies being deemed at high risk of bias using PROBAST modelling. We found statistically significant associations between elevated preoperative NLR and postoperative AKI (OR 1.45, 95% CI 1.18–1.77), as well as postoperative need for RRT (OR 2.37, 95% CI 1.50–3.72). Postoperative NLR measurements were not of prognostic significance.Conclusions
Elevated preoperative NLR is a reliable inflammatory biomarker for predicting AKI following cardiac surgery. 相似文献6.
《Revista portuguesa de cardiologia》2022,41(7):573-582
IntroductionThe management of acute coronary syndrome (ACS) in malignancy is challenging due to higher bleeding risk.MethodsWe analyzed patients with cancer (active or in the previous five years) prospectively included in the ProACS registry between 2010 and 2019. Our aim was to assess safety (major bleeding, primary endpoint) and secondary efficacy endpoints (in-hospital mortality and combined in-hospital mortality, reinfarction and ischemic stroke) of ACS treatment. Propensity score matching analysis (1:1) was further performed to better understand predictors of outcomes.ResultsWe found 934 (5%) cancer patients out of a total of 18 845 patients with ACS. Cancer patients had more events: major bleeding (2.9% vs. 1.5%), in-hospital mortality (5.8% vs. 3.4%) and the combined endpoint (7.4% vs. 4.9%). The primary endpoint was related to cancer diagnosis (OR 1.97), previous bleeding (OR 7.09), hemoglobin level (OR 4.94), atrial fibrillation (OR 3.50), oral anticoagulation (OR 3.67) and renal dysfunction. Mortality and the combined secondary endpoint were associated with lower use of invasive coronary angiography and antiplatelet and neurohormonal blocker therapy. After propensity score matching (350 patients), there were no statistically significant differences in endpoints between the populations.ConclusionBleeding risk was not significant higher in the cancer population compared to patients with similar characteristics, nor were mortality or ischemic risk. The presence of cancer should not preclude simultaneous ACS treatment. 相似文献
7.
8.
9.
10.